The global market for Olaparib Tablets was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Olaparib tablets are a PARP (poly ADP-ribose polymerase) inhibitor used to treat cancers associated with specific genetic mutations, particularly those involving BRCA1 or BRCA2 genes.

North American market for Olaparib Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Olaparib Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Olaparib Tablets include AstraZeneca, Merck, Natco Pharma, Everest Pharmaceuticals, BDR Pharmaceuticals, Qilu Pharmaceutical, Jiangsu Litaier Pharmaceuticals, Sino Therapeutics, Huadong Medicin, CSPC Ouyi Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Olaparib Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Olaparib Tablets.

The Olaparib Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Olaparib Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Olaparib Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Olaparib Tablets Market Report

Report Metric	Details
Report Name	Olaparib Tablets Market
Segment by Type	100mg per Tablet 500mg per Tablet
Segment by Application	Ovarian Cancer Breast Cancer Metastatic Prostate Cancer Metastatic Pancreatic Cancer
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	AstraZeneca, Merck, Natco Pharma, Everest Pharmaceuticals, BDR Pharmaceuticals, Qilu Pharmaceutical, Jiangsu Litaier Pharmaceuticals, Sino Therapeutics, Huadong Medicin, CSPC Ouyi Pharmaceutical, Kelun Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Olaparib Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Olaparib Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Olaparib Tablets Market report?

Ans: The main players in the Olaparib Tablets Market are AstraZeneca, Merck, Natco Pharma, Everest Pharmaceuticals, BDR Pharmaceuticals, Qilu Pharmaceutical, Jiangsu Litaier Pharmaceuticals, Sino Therapeutics, Huadong Medicin, CSPC Ouyi Pharmaceutical, Kelun Pharmaceutical

What are the Application segmentation covered in the Olaparib Tablets Market report?

Ans: The Applications covered in the Olaparib Tablets Market report are Ovarian Cancer, Breast Cancer, Metastatic Prostate Cancer, Metastatic Pancreatic Cancer

What are the Type segmentation covered in the Olaparib Tablets Market report?

Ans: The Types covered in the Olaparib Tablets Market report are 100mg per Tablet, 500mg per Tablet

1 Olaparib Tablets Market Overview

1.1 Product Definition

1.2 Olaparib Tablets by Type

1.2.1 Global Olaparib Tablets Market Value Comparison by Type (2024 VS 2031)

1.2.2 100mg per Tablet

1.2.3 500mg per Tablet

1.3 Olaparib Tablets by Application

1.3.1 Global Olaparib Tablets Market Value by Application (2024 VS 2031)

1.3.2 Ovarian Cancer

1.3.3 Breast Cancer

1.3.4 Metastatic Prostate Cancer

1.3.5 Metastatic Pancreatic Cancer

1.4 Global Olaparib Tablets Market Size Estimates and Forecasts

1.4.1 Global Olaparib Tablets Revenue 2020-2031

1.4.2 Global Olaparib Tablets Sales 2020-2031

1.4.3 Global Olaparib Tablets Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Olaparib Tablets Market Competition by Manufacturers

2.1 Global Olaparib Tablets Sales Market Share by Manufacturers (2020-2025)

2.2 Global Olaparib Tablets Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Olaparib Tablets Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Olaparib Tablets, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Olaparib Tablets, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Olaparib Tablets, Product Type & Application

2.7 Global Key Manufacturers of Olaparib Tablets, Date of Enter into This Industry

2.8 Global Olaparib Tablets Market Competitive Situation and Trends

2.8.1 Global Olaparib Tablets Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Olaparib Tablets Players Market Share by Revenue

2.8.3 Global Olaparib Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Olaparib Tablets Market Scenario by Region

3.1 Global Olaparib Tablets Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Olaparib Tablets Sales by Region: 2020-2031

3.2.1 Global Olaparib Tablets Sales by Region: 2020-2025

3.2.2 Global Olaparib Tablets Sales by Region: 2026-2031

3.3 Global Olaparib Tablets Revenue by Region: 2020-2031

3.3.1 Global Olaparib Tablets Revenue by Region: 2020-2025

3.3.2 Global Olaparib Tablets Revenue by Region: 2026-2031

3.4 North America Olaparib Tablets Market Facts & Figures by Country

3.4.1 North America Olaparib Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Olaparib Tablets Sales by Country (2020-2031)

3.4.3 North America Olaparib Tablets Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Olaparib Tablets Market Facts & Figures by Country

3.5.1 Europe Olaparib Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Olaparib Tablets Sales by Country (2020-2031)

3.5.3 Europe Olaparib Tablets Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Olaparib Tablets Market Facts & Figures by Region

3.6.1 Asia Pacific Olaparib Tablets Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Olaparib Tablets Sales by Region (2020-2031)

3.6.3 Asia Pacific Olaparib Tablets Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Olaparib Tablets Market Facts & Figures by Country

3.7.1 Latin America Olaparib Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Olaparib Tablets Sales by Country (2020-2031)

3.7.3 Latin America Olaparib Tablets Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Olaparib Tablets Market Facts & Figures by Country

3.8.1 Middle East and Africa Olaparib Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Olaparib Tablets Sales by Country (2020-2031)

3.8.3 Middle East and Africa Olaparib Tablets Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Olaparib Tablets Sales by Type (2020-2031)

4.1.1 Global Olaparib Tablets Sales by Type (2020-2025)

4.1.2 Global Olaparib Tablets Sales by Type (2026-2031)

4.1.3 Global Olaparib Tablets Sales Market Share by Type (2020-2031)

4.2 Global Olaparib Tablets Revenue by Type (2020-2031)

4.2.1 Global Olaparib Tablets Revenue by Type (2020-2025)

4.2.2 Global Olaparib Tablets Revenue by Type (2026-2031)

4.2.3 Global Olaparib Tablets Revenue Market Share by Type (2020-2031)

4.3 Global Olaparib Tablets Price by Type (2020-2031)

5 Segment by Application

5.1 Global Olaparib Tablets Sales by Application (2020-2031)

5.1.1 Global Olaparib Tablets Sales by Application (2020-2025)

5.1.2 Global Olaparib Tablets Sales by Application (2026-2031)

5.1.3 Global Olaparib Tablets Sales Market Share by Application (2020-2031)

5.2 Global Olaparib Tablets Revenue by Application (2020-2031)

5.2.1 Global Olaparib Tablets Revenue by Application (2020-2025)

5.2.2 Global Olaparib Tablets Revenue by Application (2026-2031)

5.2.3 Global Olaparib Tablets Revenue Market Share by Application (2020-2031)

5.3 Global Olaparib Tablets Price by Application (2020-2031)

6 Key Companies Profiled

6.1 AstraZeneca

6.1.1 AstraZeneca Company Information

6.1.2 AstraZeneca Description and Business Overview

6.1.3 AstraZeneca Olaparib Tablets Sales, Revenue and Gross Margin (2020-2025)

6.1.4 AstraZeneca Olaparib Tablets Product Portfolio

6.1.5 AstraZeneca Recent Developments/Updates

6.2 Merck

6.2.1 Merck Company Information

6.2.2 Merck Description and Business Overview

6.2.3 Merck Olaparib Tablets Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Merck Olaparib Tablets Product Portfolio

6.2.5 Merck Recent Developments/Updates

6.3 Natco Pharma

6.3.1 Natco Pharma Company Information

6.3.2 Natco Pharma Description and Business Overview

6.3.3 Natco Pharma Olaparib Tablets Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Natco Pharma Olaparib Tablets Product Portfolio

6.3.5 Natco Pharma Recent Developments/Updates

6.4 Everest Pharmaceuticals

6.4.1 Everest Pharmaceuticals Company Information

6.4.2 Everest Pharmaceuticals Description and Business Overview

6.4.3 Everest Pharmaceuticals Olaparib Tablets Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Everest Pharmaceuticals Olaparib Tablets Product Portfolio

6.4.5 Everest Pharmaceuticals Recent Developments/Updates

6.5 BDR Pharmaceuticals

6.5.1 BDR Pharmaceuticals Company Information

6.5.2 BDR Pharmaceuticals Description and Business Overview

6.5.3 BDR Pharmaceuticals Olaparib Tablets Sales, Revenue and Gross Margin (2020-2025)

6.5.4 BDR Pharmaceuticals Olaparib Tablets Product Portfolio

6.5.5 BDR Pharmaceuticals Recent Developments/Updates

6.6 Qilu Pharmaceutical

6.6.1 Qilu Pharmaceutical Company Information

6.6.2 Qilu Pharmaceutical Description and Business Overview

6.6.3 Qilu Pharmaceutical Olaparib Tablets Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Qilu Pharmaceutical Olaparib Tablets Product Portfolio

6.6.5 Qilu Pharmaceutical Recent Developments/Updates

6.7 Jiangsu Litaier Pharmaceuticals

6.7.1 Jiangsu Litaier Pharmaceuticals Company Information

6.7.2 Jiangsu Litaier Pharmaceuticals Description and Business Overview

6.7.3 Jiangsu Litaier Pharmaceuticals Olaparib Tablets Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Jiangsu Litaier Pharmaceuticals Olaparib Tablets Product Portfolio

6.7.5 Jiangsu Litaier Pharmaceuticals Recent Developments/Updates

6.8 Sino Therapeutics

6.8.1 Sino Therapeutics Company Information

6.8.2 Sino Therapeutics Description and Business Overview

6.8.3 Sino Therapeutics Olaparib Tablets Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Sino Therapeutics Olaparib Tablets Product Portfolio

6.8.5 Sino Therapeutics Recent Developments/Updates

6.9 Huadong Medicin

6.9.1 Huadong Medicin Company Information

6.9.2 Huadong Medicin Description and Business Overview

6.9.3 Huadong Medicin Olaparib Tablets Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Huadong Medicin Olaparib Tablets Product Portfolio

6.9.5 Huadong Medicin Recent Developments/Updates

6.10 CSPC Ouyi Pharmaceutical

6.10.1 CSPC Ouyi Pharmaceutical Company Information

6.10.2 CSPC Ouyi Pharmaceutical Description and Business Overview

6.10.3 CSPC Ouyi Pharmaceutical Olaparib Tablets Sales, Revenue and Gross Margin (2020-2025)

6.10.4 CSPC Ouyi Pharmaceutical Olaparib Tablets Product Portfolio

6.10.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates

6.11 Kelun Pharmaceutical

6.11.1 Kelun Pharmaceutical Company Information

6.11.2 Kelun Pharmaceutical Description and Business Overview

6.11.3 Kelun Pharmaceutical Olaparib Tablets Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Kelun Pharmaceutical Olaparib Tablets Product Portfolio

6.11.5 Kelun Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Olaparib Tablets Industry Chain Analysis

7.2 Olaparib Tablets Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Olaparib Tablets Production Mode & Process Analysis

7.4 Olaparib Tablets Sales and Marketing

7.4.1 Olaparib Tablets Sales Channels

7.4.2 Olaparib Tablets Distributors

7.5 Olaparib Tablets Customer Analysis

8 Olaparib Tablets Market Dynamics

8.1 Olaparib Tablets Industry Trends

8.2 Olaparib Tablets Market Drivers

8.3 Olaparib Tablets Market Challenges

8.4 Olaparib Tablets Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Merck

Natco Pharma

Everest Pharmaceuticals

BDR Pharmaceuticals

Qilu Pharmaceutical

Sino Therapeutics

CSPC Ouyi Pharmaceutical

Kelun Pharmaceutical

Jiangsu Litaier Pharmaceuticals

Huadong Medicin

List of Tables

Table 1. Global Olaparib Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Olaparib Tablets Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Olaparib Tablets Market Competitive Situation by Manufacturers in 2024

Table 4. Global Olaparib Tablets Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Olaparib Tablets Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Olaparib Tablets Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Olaparib Tablets Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Olaparib Tablets Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Olaparib Tablets, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Olaparib Tablets, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Olaparib Tablets, Product Type & Application

Table 12. Global Key Manufacturers of Olaparib Tablets, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Olaparib Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Olaparib Tablets as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Olaparib Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Olaparib Tablets Sales by Region (2020-2025) & (K Units)

Table 18. Global Olaparib Tablets Sales Market Share by Region (2020-2025)

Table 19. Global Olaparib Tablets Sales by Region (2026-2031) & (K Units)

Table 20. Global Olaparib Tablets Sales Market Share by Region (2026-2031)

Table 21. Global Olaparib Tablets Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Olaparib Tablets Revenue Market Share by Region (2020-2025)

Table 23. Global Olaparib Tablets Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Olaparib Tablets Revenue Market Share by Region (2026-2031)

Table 25. North America Olaparib Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Olaparib Tablets Sales by Country (2020-2025) & (K Units)

Table 27. North America Olaparib Tablets Sales by Country (2026-2031) & (K Units)

Table 28. North America Olaparib Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Olaparib Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Olaparib Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Olaparib Tablets Sales by Country (2020-2025) & (K Units)

Table 32. Europe Olaparib Tablets Sales by Country (2026-2031) & (K Units)

Table 33. Europe Olaparib Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Olaparib Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Olaparib Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Olaparib Tablets Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Olaparib Tablets Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Olaparib Tablets Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Olaparib Tablets Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Olaparib Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Olaparib Tablets Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Olaparib Tablets Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Olaparib Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Olaparib Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Olaparib Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Olaparib Tablets Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Olaparib Tablets Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Olaparib Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Olaparib Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Olaparib Tablets Sales (K Units) by Type (2020-2025)

Table 51. Global Olaparib Tablets Sales (K Units) by Type (2026-2031)

Table 52. Global Olaparib Tablets Sales Market Share by Type (2020-2025)

Table 53. Global Olaparib Tablets Sales Market Share by Type (2026-2031)

Table 54. Global Olaparib Tablets Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Olaparib Tablets Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Olaparib Tablets Revenue Market Share by Type (2020-2025)

Table 57. Global Olaparib Tablets Revenue Market Share by Type (2026-2031)

Table 58. Global Olaparib Tablets Price (US$/Unit) by Type (2020-2025)

Table 59. Global Olaparib Tablets Price (US$/Unit) by Type (2026-2031)

Table 60. Global Olaparib Tablets Sales (K Units) by Application (2020-2025)

Table 61. Global Olaparib Tablets Sales (K Units) by Application (2026-2031)

Table 62. Global Olaparib Tablets Sales Market Share by Application (2020-2025)

Table 63. Global Olaparib Tablets Sales Market Share by Application (2026-2031)

Table 64. Global Olaparib Tablets Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Olaparib Tablets Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Olaparib Tablets Revenue Market Share by Application (2020-2025)

Table 67. Global Olaparib Tablets Revenue Market Share by Application (2026-2031)

Table 68. Global Olaparib Tablets Price (US$/Unit) by Application (2020-2025)

Table 69. Global Olaparib Tablets Price (US$/Unit) by Application (2026-2031)

Table 70. AstraZeneca Company Information

Table 71. AstraZeneca Description and Business Overview

Table 72. AstraZeneca Olaparib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. AstraZeneca Olaparib Tablets Product

Table 74. AstraZeneca Recent Developments/Updates

Table 75. Merck Company Information

Table 76. Merck Description and Business Overview

Table 77. Merck Olaparib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Merck Olaparib Tablets Product

Table 79. Merck Recent Developments/Updates

Table 80. Natco Pharma Company Information

Table 81. Natco Pharma Description and Business Overview

Table 82. Natco Pharma Olaparib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Natco Pharma Olaparib Tablets Product

Table 84. Natco Pharma Recent Developments/Updates

Table 85. Everest Pharmaceuticals Company Information

Table 86. Everest Pharmaceuticals Description and Business Overview

Table 87. Everest Pharmaceuticals Olaparib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Everest Pharmaceuticals Olaparib Tablets Product

Table 89. Everest Pharmaceuticals Recent Developments/Updates

Table 90. BDR Pharmaceuticals Company Information

Table 91. BDR Pharmaceuticals Description and Business Overview

Table 92. BDR Pharmaceuticals Olaparib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. BDR Pharmaceuticals Olaparib Tablets Product

Table 94. BDR Pharmaceuticals Recent Developments/Updates

Table 95. Qilu Pharmaceutical Company Information

Table 96. Qilu Pharmaceutical Description and Business Overview

Table 97. Qilu Pharmaceutical Olaparib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Qilu Pharmaceutical Olaparib Tablets Product

Table 99. Qilu Pharmaceutical Recent Developments/Updates

Table 100. Jiangsu Litaier Pharmaceuticals Company Information

Table 101. Jiangsu Litaier Pharmaceuticals Description and Business Overview

Table 102. Jiangsu Litaier Pharmaceuticals Olaparib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Jiangsu Litaier Pharmaceuticals Olaparib Tablets Product

Table 104. Jiangsu Litaier Pharmaceuticals Recent Developments/Updates

Table 105. Sino Therapeutics Company Information

Table 106. Sino Therapeutics Description and Business Overview

Table 107. Sino Therapeutics Olaparib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Sino Therapeutics Olaparib Tablets Product

Table 109. Sino Therapeutics Recent Developments/Updates

Table 110. Huadong Medicin Company Information

Table 111. Huadong Medicin Description and Business Overview

Table 112. Huadong Medicin Olaparib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Huadong Medicin Olaparib Tablets Product

Table 114. Huadong Medicin Recent Developments/Updates

Table 115. CSPC Ouyi Pharmaceutical Company Information

Table 116. CSPC Ouyi Pharmaceutical Description and Business Overview

Table 117. CSPC Ouyi Pharmaceutical Olaparib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. CSPC Ouyi Pharmaceutical Olaparib Tablets Product

Table 119. CSPC Ouyi Pharmaceutical Recent Developments/Updates

Table 120. Kelun Pharmaceutical Company Information

Table 121. Kelun Pharmaceutical Description and Business Overview

Table 122. Kelun Pharmaceutical Olaparib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Kelun Pharmaceutical Olaparib Tablets Product

Table 124. Kelun Pharmaceutical Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Olaparib Tablets Distributors List

Table 128. Olaparib Tablets Customers List

Table 129. Olaparib Tablets Market Trends

Table 130. Olaparib Tablets Market Drivers

Table 131. Olaparib Tablets Market Challenges

Table 132. Olaparib Tablets Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Product Picture of Olaparib Tablets

Figure 2. Global Olaparib Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Olaparib Tablets Market Share by Type: 2024 & 2031

Figure 4. 100mg per Tablet Product Picture

Figure 5. 500mg per Tablet Product Picture

Figure 6. Global Olaparib Tablets Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Olaparib Tablets Market Share by Application: 2024 & 2031

Figure 8. Ovarian Cancer

Figure 9. Breast Cancer

Figure 10. Metastatic Prostate Cancer

Figure 11. Metastatic Pancreatic Cancer

Figure 12. Global Olaparib Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Olaparib Tablets Market Size (2020-2031) & (US$ Million)

Figure 14. Global Olaparib Tablets Sales (2020-2031) & (K Units)

Figure 15. Global Olaparib Tablets Average Price (US$/Unit) & (2020-2031)

Figure 16. Olaparib Tablets Report Years Considered

Figure 17. Olaparib Tablets Sales Share by Manufacturers in 2024

Figure 18. Global Olaparib Tablets Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Olaparib Tablets Players: Market Share by Revenue in Olaparib Tablets in 2024

Figure 20. Olaparib Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Olaparib Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Olaparib Tablets Sales Market Share by Country (2020-2031)

Figure 23. North America Olaparib Tablets Revenue Market Share by Country (2020-2031)

Figure 24. United States Olaparib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Olaparib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Olaparib Tablets Sales Market Share by Country (2020-2031)

Figure 27. Europe Olaparib Tablets Revenue Market Share by Country (2020-2031)

Figure 28. Germany Olaparib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Olaparib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Olaparib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Olaparib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Olaparib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Olaparib Tablets Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Olaparib Tablets Revenue Market Share by Region (2020-2031)

Figure 35. China Olaparib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Olaparib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Olaparib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Olaparib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Olaparib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Olaparib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Olaparib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Olaparib Tablets Sales Market Share by Country (2020-2031)

Figure 43. Latin America Olaparib Tablets Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Olaparib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Olaparib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Olaparib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Colombia Olaparib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Olaparib Tablets Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Olaparib Tablets Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Olaparib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Olaparib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Olaparib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Olaparib Tablets by Type (2020-2031)

Figure 54. Global Revenue Market Share of Olaparib Tablets by Type (2020-2031)

Figure 55. Global Olaparib Tablets Price (US$/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Olaparib Tablets by Application (2020-2031)

Figure 57. Global Revenue Market Share of Olaparib Tablets by Application (2020-2031)

Figure 58. Global Olaparib Tablets Price (US$/Unit) by Application (2020-2031)

Figure 59. Olaparib Tablets Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions